AFRM vs CCCC · P/E 590, rev $3.22B vs rev $35.6M
Affirm Holdings Inc (AFRM) versus C4 Therapeutics Inc (CCCC) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. CCCC currently screens at market cap $425.7M.
Not investment advice. Open the AFRM and CCCC stock pages for the full models.
Not investment advice.